1Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for industry considerations for plasmid DNA vaccines for infectious disease indications. US, 2005.
2Dupuis M, Denis-Mize K, Woo C, et al. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J Immunol, 2000,165 (5) : 2850-2858.
3Nishikawa M,Takakura Y, Hashida M. Theoretical considerations involving the pharmacokinetics of plasmid DNA. Adv Drug Deliv Rev,2005,57(5):675-688.
4Tuomela M,Malm M,Wallen M,et al. Biodistribution and general safety of a naked DNA plasmid, GTU-Multi HIV, in a rat, using a quantitative PCR method. Vaccine, 2005, 23 (7) : 890-896.
5Babiuk S, Baea-Estrada ME, Foldvari M, et al. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther,2003,8(6) :992-998.
6Koshkina NV. Agoulnik IY, Melton SL, et al. Biodistribution and pharmacokinetics of aerosol and intravenously adminis-tered DNA-polyethyleneimine complexes: optimization of pulmonary delivery and retention. Mol Ther,2003,8(2) :249-254.
7Dalton SR,Wiegert RL,Casey CA. Receptor-mediated endocytosis by the asialoglycoprotein receptor: effect of ethanol ad-ministration on endosomal distribution of receptor and ligand. Liver Int,2003,23(6) :484-491.
8Ward CM, Peehar M, Oupieky D, et al. Modifieation of pLL/ DNA eomplexes With a muhivalent hydrophilic polymer permits folate-mediated targeting in vitro and prolonged Plasma eireulation in vivo. J Gene Med,2002,4(5):536-547.
9Kang MJ,Kim CK, Kim MY, et al. Skin permeation,biodistribution, and expression of topically applied plasmid DNA, J Gene Med,2004,6(11) :1238-1246.
10Dauty E, Remy JS, Blessing T, et al. Dimerizable cationic detergents with a low cmc condense plasmid DNA into nanometric particles and transfect cells in culture. J Am Chem Soc, 2001, 123(38) : 9227-9234.
